תאריך/זמן
16/07/2020 / 18:00 - 20:00

 

MARK YOUR CALENDAR   SAVR vs. TAVR: Controversial Cases and Insights from the Experts Nearly 20 years since the first transcatheter aortic valve replacement (TAVR) was performed, the feasibility and effectiveness of the minimally invasive procedure have consistently been substantiated by an accumulation of rigorous, evidence-based clinical experience. With simplification of the technique, improvements in valve design, and expanded indications for patients, should TAVR replace surgical aortic valve replacement (SAVR) as the primary treatment for aortic stenosis (AS)? In the next webinar of the STS Summer Series, Gorav Ailawadi, MD, MBA, and Tsuyoshi Kaneko, MD, will talk with other SAVR/TAVR experts—cardiothoracic surgeons and cardiologists—about different approaches to AS treatment, especially in patients with: Bicuspid aortic valve Failed surgical bioprosthesis Small annulus This series is supported by Medtronic. Join Webinar Thursday, July 16 6:00 p.m. ET, 5:00 p.m. CT, 3:00 p.m. PT   Call In: 888-475-4499 or 877-853-5257 Meeting ID: 946-7178-9169 International Dial-in Numbers   Add to your calendar: Google | Outlook     Moderators Gorav Ailawadi, MD, MBA University of Virginia Charlottesville, VA Tsuyoshi Kaneko, MD Harvard Medical School, Brigham and Women’s Hospital Boston, MA     Panelists Vinayak N. Bapat, MD NewYork-Presbyterian/Columbia University Medical Center New York, NY Adam B. Greenbaum, MD Emory Healthcare Atlanta, GA Molly A. Szerlip, MD Baylor Scott & White Health Plano, TX Vinod H. Thourani, MD Piedmont Heart Institute Atlanta, GA